Asklepios Bio Pharmaceutical
GPTKB entity
Statements (65)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
2
|
| gptkbp:bfsParent |
gptkb:physicist
|
| gptkbp:acquisition |
strategic acquisitions
|
| gptkbp:ceo |
gptkb:Dr._John_M._Maraganore
|
| gptkbp:clinical_trial |
ongoing
Phase 3 trials Phase 1 trials Phase 2 trials |
| gptkbp:collaborations |
academic institutions
|
| gptkbp:employees |
over 100
|
| gptkbp:focus |
gptkb:physicist
|
| gptkbp:focus_area |
gptkb:healthcare_organization
gptkb:cystic_fibrosis gptkb:Company gptkb:DJ gptkb:Duchenne_muscular_dystrophy gptkb:psychologist Huntington's disease reproductive health metabolic disorders oncology autoimmune diseases chronic pain metabolic syndrome obesity sleep disorders infectious diseases musculoskeletal disorders pandemic preparedness skin diseases vascular diseases cognitive disorders retinal diseases gastrointestinal diseases inflammatory diseases pulmonary diseases endocrine disorders thyroid disorders aging-related diseases infectious disease outbreaks muscular dystrophies adrenal disorders pituitary disorders renal diseases cardiac diseases |
| gptkbp:founded |
gptkb:2001
|
| gptkbp:founder |
gptkb:Dr._John_M._Maraganore
|
| gptkbp:headquarters |
gptkb:Cary,_North_Carolina
|
| https://www.w3.org/2000/01/rdf-schema#label |
Asklepios Bio Pharmaceutical
|
| gptkbp:investment |
various venture capital firms
|
| gptkbp:language_of_instruction |
multiple product candidates
|
| gptkbp:mission |
advancing gene therapies
|
| gptkbp:partnership |
biopharmaceutical companies
|
| gptkbp:partnerships |
various pharmaceutical companies
|
| gptkbp:products |
AAV-based gene therapies
|
| gptkbp:regulatory_compliance |
FDA approvals
|
| gptkbp:research |
gptkb:Dr._Jane_Smith
|
| gptkbp:research_areas |
neurological disorders
cardiovascular diseases rare genetic disorders |
| gptkbp:research_focus |
treatment of genetic diseases
|
| gptkbp:technology |
Adeno-Associated Virus (AAV) technology
|
| gptkbp:vision |
transforming lives through gene therapy
|
| gptkbp:website |
www.asklepiosbiopharmaceutical.com
|